Newsfeeds Archive - Page 4 of 4

1 minute read

BMO Capital Maintains Market Perform on Pacira BioSciences, Lowers Price Target to $60

November 7, 9:43 AM

BMO Capital analyst Gary Nachman maintains Pacira BioSciences (NASDAQ:PCRX) with a Market Perform and lowers the price target from $66 to $60.

1 minute read

November 3, 1:34 PM

Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and lowers the price target from $76 to $74.

31 minute read

November 3, 5:42 AM

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

4 minute read

September 7, 5:45 PM

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6…